Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shandong Weigao Blood Purification Products Co's quarterly Total Liabilities
increased
from Sep. 2025 (¥1,486.19 Mil) to Dec. 2025 (¥1,489.77 Mil) but then
declined
from Dec. 2025 (¥1,489.77 Mil) to Mar. 2026 (¥1,342.23 Mil).
Shandong Weigao Blood Purification Products Co's annual Total Liabilities
declined
from Dec. 2023 (¥1,545.49 Mil) to Dec. 2024 (¥1,393.37 Mil) but then
increased
from Dec. 2024 (¥1,393.37 Mil) to Dec. 2025 (¥1,489.77 Mil).
Shandong Weigao Blood Purification Products Co Total Liabilities Related Terms
Shandong Weigao Blood Purification Products Co Total Liabilities Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Blood Purification Products Co Total Liabilities Chart
Shandong Weigao Blood Purification Products Co Annual Data
Shandong Weigao Blood Purification Products Co Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a Total Liabilities of ¥1,342 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Shandong Weigao Blood Purification Products Co and its competitors.
Is Shandong Weigao Blood Purification Products Co's Total Liabilities too high?
Shandong Weigao Blood Purification Products Co's current Total Liabilities is ¥1,342 Mil. Overall, Shandong Weigao Blood Purification Products Co has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Blood Purification Products Co's Total Liabilities compare to ABT and SYK?
Shandong Weigao Blood Purification Products Co's Total Liabilities of ¥1,342 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Shandong Weigao Blood Purification Products Co and its competitors. Shandong Weigao Blood Purification Products Co's current Total Liabilities is ¥1,342 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Blood Purification Products Co stock overvalued right now?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a current Total Liabilities of ¥1,342 Mil. The current Total Liabilities is ¥1,342 Mil. Shandong Weigao Blood Purification Products Co's overall GF Score™ is 36/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Shandong Weigao Blood Purification Products Co (SHSE:603014), the current Total Liabilities is ¥1,342 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shandong Weigao Blood Purification Products Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603014 has been successfully added to your 
